multiple sclerosis

Pharmalot Ed Silverman

STAT Plus: Multiple sclerosis patients see drug value differently than payers and doctors

First Opinion Brian C. Callaghan and Lindsey De Lott

Medicare shouldn’t pay more for drugs when others pay less

Pharmalot Ed Silverman

Insurers pay more for multiple sclerosis drug because rebates don’t help, report says

Exclusive Sharon Begley

Bold claim of multiple sclerosis gene discovery comes under withering attack

Health Usha Lee McFarling

FDA weighs crackdown that could shut hundreds of stem cell clinics

Health Leah Samuel

Architect with ALS designs a residence he can control with just blinks

In the Lab Sharon Begley

Discovery of multiple sclerosis gene could inspire new therapies — if it’s right

Pharmalot Ed Silverman

Biogen puzzles Wall Street with plans to spin off its hemophilia business